A single-center, randomized, double-blinded, placebo-controlled clinical study on the efficacy and safety of voriconazole ear drops in the treatment of otomycosis
Open Access
- 13 January 2026
- journal article
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 47 (1) , 104792
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hunan Province (2025JJ80176)
This publication has 19 references indexed in Scilit:
- Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agentsJournal of Medical Microbiology, 2019
- Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agentJournal of Medical Microbiology, 2019
- The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, JapanMycopathologia, 2018
- Otomycosis in immunocompetent patients: Clinical and mycological features. Our experience with 40 casesClinical Otolaryngology, 2017
- Otomycosis in Iran: A ReviewMycopathologia, 2015
- Treatment of refractory Aspergillus otomycosis with voriconazole: case series and reviewThe Journal of Laryngology & Otology, 2014
- Otomycosis due to Filamentous FungiMycopathologia, 2011
- Otomycosis: Diagnosis and treatmentClinics in Dermatology, 2010
- Aspergillus flavus: human pathogen, allergen and mycotoxin producerMicrobiology, 2007
- Otomycosis: Clinical features and treatment implicationsOtolaryngology–Head and Neck Surgery, 2006